| 1 |
35356807 | Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models. | 2022 Jan-Dec |
2 |
| 2 |
35422863 | The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects. | 2022 |
1 |
| 3 |
34100981 | Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination. | 2021 Jul |
1 |
| 4 |
34676045 | ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide. | 2021 Oct 12 |
1 |
| 5 |
30361254 | Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB. | 2019 Jan 1 |
1 |
| 6 |
28852018 | Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma. | 2017 Aug 29 |
1 |
| 7 |
26972001 | Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins. | 2016 Mar 22 |
3 |
| 8 |
25337721 | Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide. | 2014 Nov 15 |
1 |
| 9 |
22977194 | FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51. | 2012 Nov 1 |
3 |
| 10 |
21363882 | Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. | 2011 May |
2 |
| 11 |
22073281 | Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs. | 2011 |
1 |